Fundación Epic
Clinical trials sponsored by Fundación Epic, explained in plain language.
-
Heart device under watch: 2,000-Patient study launches
Disease control Recruiting nowThis study follows over 2,000 patients with coronary artery disease who received a device called Sequent Please Neo during routine care. Researchers want to confirm the device is safe and works well by tracking major heart problems like heart attacks or the need for repeat proced…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New stent study aims to keep heart patients alive and well
Disease control Recruiting nowThis study looks at how well the SUPRAFLEX CRUZ stent works in people with blocked heart arteries. About 508 adults who already got the stent as part of their normal care will be followed for 12 months. Researchers will track serious heart problems like heart attacks or the need …
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
One stent to cover the long haul: new study tests Extra-Long heart stents
Disease control Recruiting nowThis study is testing a very long stent (a mesh tube) to treat long blockages in the heart's arteries. About 1,000 people with coronary artery disease will get one long stent instead of multiple shorter ones. The goal is to see if this approach is safe and works well at keeping t…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New heart stent under watch: 3,000 patients enrolled in global safety study
Disease control Recruiting nowThis study is checking how well a new drug-coated heart stent (Coroflex ISAR NEO) works and how safe it is in 3,000 people with narrowed heart arteries. Participants get the stent as part of their regular care, and doctors will track heart-related events like heart attacks or the…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New balloon treatment for heart disease under real-world watch
Disease control Recruiting nowThis study is a registry that will follow about 960 people with coronary artery disease who are treated with a special balloon coated with a drug called sirolimus. The balloon is used to open blocked arteries and release medicine to keep them open. Researchers will track heart-re…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Stenting hidden danger zones after heart attack could save lives
Disease control Recruiting nowThis study looks at people who recently had a major heart attack (STEMI) and have multiple blocked arteries. Doctors want to see if placing stents in unstable-looking plaques (that aren't severely blocking blood flow) plus medication is better than medication alone to prevent fut…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New balloon treatment may reduce bleeding risk in heart patients
Disease control Recruiting nowThis study tests a drug-coated balloon (DCB) to treat small heart arteries in people with coronary artery disease who also have a high risk of bleeding. About 501 participants will receive the balloon treatment and then take only 7 days of blood thinners instead of the usual long…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New heart test could replace needles and drugs
Knowledge-focused Recruiting nowThis study looks at a simpler method to check if heart artery treatments worked well. Instead of using a drug that can cause side effects, doctors will use a special wire and nitroglycerin to measure blood flow. About 150 people with blockages in multiple heart arteries will take…
Phase: NA • Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC